Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-eNOS Antibody (8V329) is a Mouse antibody targeting eNOS. Anti-eNOS Antibody (8V329) can be used in WB.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 μL | $216 | 7-10 days | 7-10 days | |
| 100 μL | $316 | 7-10 days | 7-10 days |
| Description | Anti-eNOS Antibody (8V329) is a Mouse antibody targeting eNOS. Anti-eNOS Antibody (8V329) can be used in WB. |
| Synonyms | NOSIII, NOS-3, NOS3, NOS type III, NOS III, NOS 3, nitric oxide synthase, endothelial, Nitric oxide synthase endothelial, Nitric oxide synthase 3(endothelial cell), Nitric oxide synthase 3 endothelial cell, Nitric oxide synthase 3, Endothelial NOS, Endothelial nitric oxide synthase 3, Endothelial nitric oxidase synthase, ecNOS, EC NOS, Constitutive NOS, cNOS |
| Clone | 8V329 |
| Reactivity | Human,Rat,Mouse |
| Verified Activity | 1. Western blot analysis of Rat Heart Tissue, using TMAC-01301 diluted at 1:1,000. ![]() |
| Application | |
| Recommended Dose | WB: 1:1000-5000 |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | Hybridoma Monoclonal Antibody |
| Purification | Affinity purification using immunogen. |
| Appearance | Liquid |
| Formulation | PBS, pH 7.4, containing 0.02% sodium azide as Preservative and 50% Glycerol. |
| Research Background | Nitric oxide synthases (EC 1.14.13.39) (NOSs) are a family of enzymes catalyzing the production of nitric oxide (NO) from L-arginine. NO is an important cellular signaling molecule. Endothelial NOS (eNOS), also known as nitric oxide synthase 3 (NOS3), generates NO in blood vessels and is involved with regulating vascular function. |
| Conjucates | Unconjugated |
| Uniprot ID |
| Molecular Weight | Actual: 130 kDa. |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.